Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
  • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
  • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
  • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
  • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/47—Quinolines; Isoquinolines
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
  • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
  • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
  • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
  • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
  • G01N33/57407—Specifically defined cancers
  • G01N33/57423—Specifically defined cancers of lung

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• Medicinal Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Pharmacology & Pharmacy (AREA)
• Animal Behavior & Ethology (AREA)
• Epidemiology (AREA)
• Engineering & Computer Science (AREA)
• Immunology (AREA)
• Biomedical Technology (AREA)
• Hematology (AREA)
• Urology & Nephrology (AREA)
• Molecular Biology (AREA)
• Biotechnology (AREA)
• Physics & Mathematics (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Cell Biology (AREA)
• General Chemical & Material Sciences (AREA)
• Microbiology (AREA)
• Oncology (AREA)
• Hospice & Palliative Care (AREA)
• Food Science & Technology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Analytical Chemistry (AREA)
• Biochemistry (AREA)
• General Physics & Mathematics (AREA)
• Pathology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Plural Heterocyclic Compounds (AREA)
• Pyridine Compounds (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Nitrogen Condensed Heterocyclic Rings (AREA)

Applications Claiming Priority (4)

Publications (3)

Family

ID=42132177

Family Applications (1)

Country Status (36)

Families Citing this family (14)

Family Cites Families (10)

• 2009
  • 2009-10-25 JO JOP/2009/0395A patent/JO3067B1/ar active
  • 2009-10-26 TW TW98136145A patent/TWI454467B/zh not_active IP Right Cessation
  • 2009-10-26 UY UY32200A patent/UY32200A/es not_active Application Discontinuation
  • 2009-10-27 PE PE2011000920A patent/PE20110941A1/es not_active Application Discontinuation
  • 2009-10-27 ES ES09829580.1T patent/ES2539835T3/es active Active
  • 2009-10-27 JP JP2011533421A patent/JP5642689B2/ja active Active
  • 2009-10-27 NZ NZ59247709A patent/NZ592477A/xx not_active IP Right Cessation
  • 2009-10-27 SI SI200931192T patent/SI2421537T1/sl unknown
  • 2009-10-27 US US12/606,390 patent/US20100113475A1/en not_active Abandoned
  • 2009-10-27 DK DK09829580.1T patent/DK2421537T3/da active
  • 2009-10-27 CN CN2009801526261A patent/CN102264371B/zh active Active
  • 2009-10-27 AU AU2009320144A patent/AU2009320144B2/en not_active Ceased
  • 2009-10-27 AR ARP090104137 patent/AR073993A1/es not_active Application Discontinuation
  • 2009-10-27 RS RS20150365A patent/RS54045B1/en unknown
  • 2009-10-27 SG SG2013079579A patent/SG195608A1/en unknown
  • 2009-10-27 MY MYPI2011001828A patent/MY161890A/en unknown
  • 2009-10-27 PT PT98295801T patent/PT2421537E/pt unknown
  • 2009-10-27 EP EP20090829580 patent/EP2421537B1/en active Active
  • 2009-10-27 WO PCT/US2009/062163 patent/WO2010062578A1/en active Application Filing
  • 2009-10-27 CA CA2741760A patent/CA2741760C/en active Active
  • 2009-10-27 PL PL09829580T patent/PL2421537T3/pl unknown
  • 2009-10-27 KR KR1020117011999A patent/KR101512217B1/ko active IP Right Grant
  • 2009-10-27 US US13/126,064 patent/US20110207743A1/en not_active Abandoned
  • 2009-10-27 BR BRPI0920053A patent/BRPI0920053B8/pt active IP Right Grant
  • 2009-10-27 MX MX2011004369A patent/MX2011004369A/es active IP Right Grant
  • 2009-10-27 EA EA201170617A patent/EA021927B1/ru not_active IP Right Cessation
• 2011
  • 2011-04-17 IL IL212444A patent/IL212444A/en not_active IP Right Cessation
  • 2011-04-18 ZA ZA2011/02892A patent/ZA201102892B/en unknown
  • 2011-04-22 MA MA33791A patent/MA32727B1/fr unknown
  • 2011-04-26 CL CL2011000933A patent/CL2011000933A1/es unknown
  • 2011-04-27 DO DO2011000113A patent/DOP2011000113A/es unknown
  • 2011-04-29 US US13/097,271 patent/US20110269774A1/en not_active Abandoned
  • 2011-05-11 CO CO11058067A patent/CO6361929A2/es active IP Right Grant
  • 2011-05-17 CR CR20110264A patent/CR20110264A/es unknown
• 2012
  • 2012-03-05 HK HK12102201.7A patent/HK1161680A1/xx not_active IP Right Cessation
• 2013
  • 2013-10-07 US US14/047,688 patent/US9012479B2/en active Active
• 2015
  • 2015-03-30 US US14/672,477 patent/US20150265589A1/en not_active Abandoned
  • 2015-05-18 HR HRP20150531TT patent/HRP20150531T1/hr unknown
  • 2015-05-22 CY CY20151100462T patent/CY1116399T1/el unknown
  • 2015-07-03 SM SM201500157T patent/SMT201500157B/xx unknown
  • 2015-10-20 US US14/887,763 patent/US9446034B2/en active Active

Also Published As

Similar Documents

Legal Events